XML 43 R25.htm IDEA: XBRL DOCUMENT v3.8.0.1
Stock Compensation Plans (Tables)
12 Months Ended
Feb. 03, 2018
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]  
Common Stock Shares Issued to Non-Employee Directors as Compensation

The following shares of common stock, with the respective fair value, were issued to its non-employee directors as compensation for fiscal 2017, fiscal 2016 and fiscal 2015:

 

 

 

Number of shares of

common stock issued

 

 

Fair value of

common stock issued

 

Fiscal 2017

 

 

42,450

 

 

$

96,856

 

Fiscal 2016

 

 

14,509

 

 

$

68,456

 

Fiscal 2015

 

 

24,947

 

 

$

127,734

 

 

Employee Stock Plan, 2006 Plan and 2016 Plan  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]  
Stock Option Activity

The following table summarizes stock option activity under the plans for fiscal 2017:

 

 

 

Number of

Shares

 

 

Weighted-average

exercise price

per option

 

 

Weighted-average

remaining

contractual term

 

Aggregate

intrinsic value

 

Stock Options

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding options at beginning of year

 

 

2,524,546

 

 

$

4.98

 

 

 

 

 

 

 

Options granted

 

 

30,000

 

 

$

1.85

 

 

 

 

 

 

 

Options canceled

 

 

(1,358,636

)

 

$

5.04

 

 

 

 

 

 

 

Options exercised

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding options at end of year

 

 

1,195,910

 

 

$

4.80

 

 

4.4 years

 

$

21,750

 

Options exercisable at end of year

 

 

1,175,910

 

 

$

4.85

 

 

4.4 years

 

$

7,250

 

Vested and expected to vest at end of year

 

 

1,195,910

 

 

$

4.80

 

 

4.4 years

 

$

21,750

 

 

Summary of Restricted Stock Activity

The following table summarizes activity for non-vested shares under the plans for fiscal 2017:

 

 

 

Restricted shares

 

 

Restricted Stock Units (1)

 

 

Deferred shares (2)

 

 

Fully-vested

shares (3)

 

 

Total number of shares

 

 

Weighted-average

grant-date

fair value (4)

 

Shares

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding non-vested shares at beginning of

   year

 

 

856,332

 

 

 

369,828

 

 

 

64,876

 

 

 

 

 

 

1,291,036

 

 

$

5.09

 

Shares granted

 

 

484,558

 

 

 

838,546

 

 

 

100,554

 

 

 

86,503

 

 

 

1,510,161

 

 

$

2.64

 

Shares vested/issued

 

 

(447,003

)

 

 

(42,453

)

 

 

(49,973

)

 

 

(86,503

)

 

 

(625,932

)

 

$

2.71

 

Shares canceled

 

 

(857,221

)

 

 

(117,369

)

 

 

 

 

 

 

 

 

(974,590

)

 

$

4.87

 

Outstanding non-vested shares at end of year

 

 

36,666

 

 

 

1,048,552

 

 

 

115,457

 

 

 

 

 

 

1,200,675

 

 

$

3.43

 

Vested and expected to vest at end of year

 

 

36,666

 

 

 

891,269

 

 

 

115,457

 

 

 

 

 

 

1,043,392

 

 

 

 

 

 

(1)

Restricted Stock Units (“RSU”s) were primarily granted in connection with the time-vested portion of the 2017-2018 LTIP.  The RSUs vest in two tranches with the first 50% vesting on April 1, 2019 and the remaining vesting 50% on April 1, 2020.

(2)

The 100,554 shares of deferred stock, with a fair value of approximately $232,064, represent compensation to certain directors in lieu of cash, in accordance with their irrevocable elections.  The shares of deferred stock vest three years from the date of grant or at separation of service, based on the irrevocable election of each director.

(3)

During fiscal 2017, the Company granted 86,503 shares of stock, with a fair value of approximately $204,477 to certain directors as compensation in lieu of cash, in accordance with their irrevocable elections.  Directors are required to elect 50% of their quarterly retainer in equity.  Any shares in excess of the minimum required election are issued from the Third Amended and Restated Non-Employee Director Stock Purchase Plan (the “Non-Employee Director Compensation Plan”).  

(4)

The fair value of a restricted share, deferred share and fully-vested share is equal to the Company’s closing stock price on the date of grant.